These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3936866)

  • 21. Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial.
    Limaye AP; Stapleton RD; Peng L; Gunn SR; Kimball LE; Hyzy R; Exline MC; Files DC; Morris PE; Frankel SK; Mikkelsen ME; Hite D; Enfield KB; Steingrub J; O'Brien J; Parsons PE; Cuschieri J; Wunderink RG; Hotchkin DL; Chen YQ; Rubenfeld GD; Boeckh M
    JAMA; 2017 Aug; 318(8):731-740. PubMed ID: 28829877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life.
    Bussel JB; Eldor A; Kelton JG; Varon D; Brenner B; Gillis S; Angiolillo A; Kulkarni R; Abshire TC; Kelleher J;
    Thromb Haemost; 2004 Apr; 91(4):771-8. PubMed ID: 15045139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulatory role of intravenous gammaglobulin (IgIV) on the in vitro antibody response to a pneumococcal polysaccharide antigen.
    Leiva LE; Monjure H; Sorensen RU
    J Clin Immunol; 2015 Feb; 35(2):206-12. PubMed ID: 25504423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection.
    ; Cometta A; Baumgartner J-D; Lee ML; Hanique G; Glauser M-P
    N Engl J Med; 1992 Jul; 327(4):234-40. PubMed ID: 1614464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylaxis and treatment of pneumococcal bacteremia by immune globulin intravenous in a mouse model.
    Chudwin DS
    Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 1):62-71. PubMed ID: 2491979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin for prevention of sepsis in preterm and low birth weight infants.
    Haque KN; Zaidi MH; Haque SK; Bahakim H; el-Hazmi M; el-Swailam M
    Pediatr Infect Dis; 1986; 5(6):622-5. PubMed ID: 3099267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic effectiveness of an intravenous immunoglobulin with pH 4.25 in experimental neonatal sepsis caused by Klebsiella pneumoniae].
    Mancilla-Ramírez J; Nurko-Shein S; Castellanos-Cruz C; Santos-Preciado JI
    Bol Med Hosp Infant Mex; 1989 Feb; 46(2):89-93. PubMed ID: 2496700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial.
    Krueger WA; Lenhart FP; Neeser G; Ruckdeschel G; Schreckhase H; Eissner HJ; Forst H; Eckart J; Peter K; Unertl KE
    Am J Respir Crit Care Med; 2002 Oct; 166(8):1029-37. PubMed ID: 12379544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial.
    Pugin J; Auckenthaler R; Lew DP; Suter PM
    JAMA; 1991 May 22-29; 265(20):2704-10. PubMed ID: 2023353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants.
    DeJonge M; Burchfield D; Bloom B; Duenas M; Walker W; Polak M; Jung E; Millard D; Schelonka R; Eyal F; Morris A; Kapik B; Roberson D; Kesler K; Patti J; Hetherington S
    J Pediatr; 2007 Sep; 151(3):260-5, 265.e1. PubMed ID: 17719934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery.
    DeRiso AJ; Ladowski JS; Dillon TA; Justice JW; Peterson AC
    Chest; 1996 Jun; 109(6):1556-61. PubMed ID: 8769511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective and opsonic activities of a native, pH 4.25 intravenous immunoglobulin G preparation against common bacterial pathogens.
    Hill HR; Bathras JM
    Rev Infect Dis; 1986; 8 Suppl 4():S396-400. PubMed ID: 3092306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial.
    Calandra T; Glauser MP; Schellekens J; Verhoef J
    J Infect Dis; 1988 Aug; 158(2):312-9. PubMed ID: 3136210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic prophylaxis of respiratory tract infection in mechanically ventilated patients. A prospective, blinded, randomized trial of the effect of a novel regimen.
    Aerdts SJ; van Dalen R; Clasener HA; Festen J; van Lier HJ; Vollaard EJ
    Chest; 1991 Sep; 100(3):783-91. PubMed ID: 1889273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective, randomized, double-blind study using prophylactic cephalothin for major, elective, general thoracic operations.
    Ilves R; Cooper JD; Todd TR; Pearson FG
    J Thorac Cardiovasc Surg; 1981 Jun; 81(6):813-7. PubMed ID: 7015020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and tolerability of immune globulin intravenous (human), 10% solution in Japanese subjects with mild to moderate Alzheimer's disease.
    Arai H; Ichimiya Y; Shibata N; Nakajima T; Sudoh S; Tokuda T; Sujaku T; Yokokawa S; Hoshii N; Noguchi H; Bille A
    Psychogeriatrics; 2014 Sep; 14(3):165-74. PubMed ID: 25186799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
    Latov N; Deng C; Dalakas MC; Bril V; Donofrio P; Hanna K; Hartung HP; Hughes RA; Merkies IS; van Doorn PA;
    Arch Neurol; 2010 Jul; 67(7):802-7. PubMed ID: 20457948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Site of Care on Infection Rates Among Patients with Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin Therapy.
    Wasserman RL; Ito D; Xiong Y; Ye X; Bonnet P; Li-McLeod J
    J Clin Immunol; 2017 Feb; 37(2):180-186. PubMed ID: 28160239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants.
    Bloom B; Schelonka R; Kueser T; Walker W; Jung E; Kaufman D; Kesler K; Roberson D; Patti J; Hetherington S;
    Pediatr Infect Dis J; 2005 Oct; 24(10):858-66. PubMed ID: 16220082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
    Tricarico D; Varricchio A; D'Ambrosio S; Ascione E; Motta G
    Arzneimittelforschung; 2004; 54(1):57-63. PubMed ID: 14979610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.